Trevi Therapeutics Inc (TRVI) returns
Trevi Therapeutics returns over 5 years
$1,000 invested in Trevi Therapeutics five years ago was worth $11,540 at the close on October 30, 2026, with dividends reinvested: an average return of 63.1% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -5.3% | — | $946.93 | -0.9% |
| 3 months | -26.3% | — | $736.96 | +2.1% |
| Year to date | +8.3% | — | $1,083 | +11.7% |
| 1 year | +21.4% | — | $1,214 | +12.4% |
| 3 years | +641.0% | +95.0% | $7,410 | +88.5% |
| 5 years | +1,054% | +63.1% | $11,540 | +76.0% |
Trevi Therapeutics return by calendar year
| Year | TRVI | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +8.3% | +11.7% | -3.4% |
| 2025 | +203.9% | +17.7% | +186.2% |
| 2024 | +207.5% | +24.9% | +182.6% |
| 2023 | -30.6% | +26.2% | -56.8% |
| 2022 | +146.7% | -18.2% | +164.9% |
| 2021 | -67.7% | +28.7% | -96.4% |
| 2020 | -35.5% | +18.4% | -53.8% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also:
No forecast, no recommendation. This page describes Trevi Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.